GLP-1 Tribe

Weight stigma—often referred to as fatphobia or weight bias—pervades many aspects of life, from healthcare and employment to everyday social interactions. This bias assumes that larger bodies are less desirable, less disciplined, or even less worthy. Meanwhile, a new class of medications known as GLP-1 agonists (including brand names like Ozempic and Wegovy ) has made significant weight loss more...

How can a drug for weight loss and diabetes cure addiction to substances?   Researchers and patients of GLP-1 medications are seeing significant reductions on addiction to drugs and alcohol.  GLP-1 Agonists: A New Frontier in Addiction Treatment Join us as we do a deep dive on this promising research that could save hundreds of thousands of lives. This is the official podcast of the patient led co...

This episode serves as a patient guide for individuals using GLP-1 medications , explaining their mechanisms and benefits for managing type 2 diabetes and promoting weight loss. It emphasizes nutritional strategies focusing on protein and fiber, recommends creating a sustainable fitness plan with both aerobic and strength training, and discusses the potential role of supplements to address nutriti...

We introduce our podcast at GLP-1 Tribe with an overview of everything people considering taking GLP-1 medications need to know.  And why are millions of Americans taking these medicines?  GLP-1 receptor agonists , a class of medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), explaining their mechanisms of action , approved uses for type 2 diabetes and weight...